Anticipating a 35% CAGR in 2025, Hims & Hers is poised for substantial growth. Read why I maintain my strong buy rating on ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

Here’s why What kind of music makes you most productive at work? Here’s what the ... s drug shortage list. However, Hims’ weight-loss injection does not use tirzepatide.

The Aam Aadmi Party (AAP) accuses corrupt officials of sabotaging the digitization of payments in the Delhi health sector by promoting a flawed hospital information management system (HIMS), impacting ...

Friday’s jobs report could bolster the view that the American economy is holding steady, but an oil price shock could ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

When you think of health care, what do you picture? Many of us see doctors in white coats and nurses wearing scrubs, but we don’t think of the people behind the scenes who ensure everything runs ...

As the Department of Health and Human Services considers how to regulate artificial intelligence in the multibillion-dollar health care sector, Pulse spoke with one of the agency’s leading AI policy ...

Heart disease is a type of cardiovascular disease that affects the heart’s structure and function. Several different heart ...

Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration said Eli Lilly's popular weight-loss drugs ...